Audience question from Avik Roy during the #debate: Is the FDA too Cautious? #aspenideas
July 21, 2023
271
3
2
1.85%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Open to Debate Episodes Around July 21, 2023
See what was published immediately before and after this episode.
2:45Now PlayingAudience question from Avik Roy during the #debate: Is the FDA too Cautious? #aspenideas
Segments
YouTube Description
as posted by the channelDuring the COVID-19 pandemic, the Atlantic criticized the US Food and Drug Administration for moving too slowly to approve vaccines with the provocative headline “The Death Toll of Delay.” Not long before, National Public Radio ran a piece titled “One-Third of New Drugs Had Safety Problems After FDA Approval.” As the agency tries to move safe and effective drugs as quickly as possible to patients who need them, it also needs to maintain the diligence and rigor necessary to prevent harm. Two experts look at the pace of FDA approvals and argue about whether the agency is getting it right.
Arguing "YES" is Colin Hill, CEO & Co-Founder of Aitia
Arguing "NO" is Peter Lurie, physician, President of the Center for Science in the Public Interest, and former Associate Commissioner of the Food and Drug Administration
Emmy Award-winning journalist John Donvan moderates.
This debate took place live at the Aspen Institute in partnership with the Aspen Ideas Festival. @aspenideas @aspeninstitute @CDC @US_FDA
===================================
Official site
Open to Debate Apple Podcasts
Open to Debate Spotify Podcasts
===================================
-~-~~-~~~-~~-~-
Please watch: "Unresolved: The Iran Threat"
-~-~~-~~~-~~-~-
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.